Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Global Bond · BNY Mellon / Dreyfus

BNY Mellon Global Equity Income Fund Class C (DEQCX)

Ticker DEQCX · · Holdings as of Jul 31, 2026

Expense ratio
2.04%$204/yr per $10k
5-yr return
+9.1%annualized
1-yr return
+22.4%as of Dec 2025
Net assets
$213.3Mall share classes
Holdings
63

Bottom line

Is DEQCX a good fund? The bottom line

DEQCX is the Class C share class of BNY Mellon Global Equity Income Fund, an actively managed global bond mutual fund from BNY Mellon / Dreyfus.

It charges 2.04% — about $204 a year on every $10,000 invested, more expensive than 98% of global bond funds we track.

It returned +22.4% over one year, +9.1% a year over five years, +9.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $213 million in net assets and 63 holdings, its largest position is Dreyfus Institutional Preferred Money Market Funds (3.6%) and the top 10 make up 24.4% of the portfolio.

What stands out

  • 5-year return beat 85% of category peers
  • No front-end sales load

What to watch

  • Expensive for its category (2.04%)
  • 12b-1 marketing fee of 0.75% a year

Updated Nov 19, 2026

What DEQCX invests in

The fund seeks total return (consisting of capital appreciation and income).

To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities. The fund seeks to focus on dividend-paying stocks of companies located in the developed capital markets, such as the United States, Canada, Japan, Australia, Hong Kong and Western Europe. Although the fund's investments will be focused among the major developed markets of the world, the fund may invest up to 30% of its assets in emerging markets. The fund ordinarily invests in at least three countries, and, at times, may invest a substantial portion of its assets in a single country. The fund's sub-adviser, Newton Investment Management Limited, an affiliate of BNY Mellon Investment Adviser, Inc., typically will purchase stocks that, at the time of initial purchase, have a yield premium to the yield of the FTSE World Index, the fund's…

From the fund's prospectus (filed Feb 26, 2026).

DEQCX performance

Average annual total returns
1 yr5 yr10 yr
DEQCX+22.4%+9.1%+9.0%
Global Bond median+8.9%+1.1%+2.9%

Source: Fund prospectus, as of Dec 31, 2025

Full DEQCX performance history →

What DEQCX costs

On a $10,000 investment, DEQCX's 2.04% expense ratio costs about $204 a year. The prospectus estimates $2,369 in total costs over 10 years (assuming 5% annual returns). The median global bond fund charges 0.89%.

See the full DEQCX fee table →

DEQCX top 10 holdings

#Holding% of fund
1Dreyfus Institutional Preferred Money Market Funds3.60%
2Aia Group Ltd 12992.59%
3Gilead Sciences Inc GILD2.51%
4Cme Group Inc CME2.51%
5Unitedhealth Group Inc UNH2.47%
6Bae Systems Plc BA/2.26%
7Industria De Diseno Textil Sa ITX2.20%
8Barclays Plc BARC2.16%
9Expand Energy Corp CHK2.05%
10Smurfit Westrock Plc SW2.05%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 24.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to DEQCX

More funds like DEQCX →

DEQCX FAQ

What is the expense ratio of DEQCX?
DEQCX's expense ratio is 2.04%, which works out to about $204 a year for every $10,000 invested. The prospectus estimates total costs of $2,369 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DEQCX a good investment?
It depends on your goals, but the data points to: 5-year return beat 85% of category peers; no front-end sales load; expensive for its category (2.04%); 12b-1 marketing fee of 0.75% a year. This is general information, not personalized advice.
What does DEQCX hold?
DEQCX's largest holdings are Dreyfus Institutional Preferred Money Market Funds (3.6%), Aia Group Ltd (2.6%), Gilead Sciences Inc (2.5%), Cme Group Inc (2.5%), Unitedhealth Group Inc (2.5%). It holds 63 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is DEQCX's 5-year return?
DEQCX returned +9.1% a year over the five years ending Dec 31, 2025, and +9.0% a year over ten years. Past performance does not guarantee future results.
Does DEQCX have a sales load?
No. DEQCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages DEQCX?
DEQCX is offered by BNY Mellon / Dreyfus through BNY Mellon Investment Funds III.